Publication:
Factors Involved in the Immunological Protection against Rabies Virus in Dogs in Spain

dc.contributor.authorManzano, María Dolores
dc.contributor.authorCereza, Javier
dc.contributor.authorGarcía, Jesús
dc.contributor.authorYus, Luis Javier
dc.contributor.authorBadiola, Juan José
dc.contributor.authorEchevarria, Juan Emilio
dc.contributor.authorMonzón, Marta
dc.contributor.funderGobierno de Aragón (España)
dc.date.accessioned2025-01-10T16:22:24Z
dc.date.available2025-01-10T16:22:24Z
dc.date.issued2024-03-11
dc.description.abstractRabies, a viral disease spread by infected animal bites that causes encephalitis in humans and other mammals, is a neglected infectious disease present on all continents except Antarctica. Spain has been free of terrestrial rabies since 1978. However, due to its geographical situation, it represents a bridge for imported cases from an endemic continent such as Africa to Europe. Rabies vaccination in dogs is an essential preventive tool against this zoonosis. The aim of this study was to determine the state of the immune response against rabies virus in dogs in Spain and to demonstrate whether several factors that have been previously related to the influence of the seroprevalence of this species are involved here. The seroconversion level of this zoonotic virus was assessed in a total of 1060 animals. Indirect ELISA was used to obtain data for statistical analysis to evaluate the studied variables. Working under the concept of One Health, this study provides relevant information to be taken into consideration not only to prevent re-emergence in countries free of this disease but also for prevention and control in endemic countries.
dc.description.peerreviewed
dc.description.sponsorshipFinancial support from the Government of Aragon.
dc.format.number3
dc.format.page293
dc.format.volume12
dc.identifier.citationManzano MD, Cereza J, García J, Yus LJ, Badiola JJ, Echevarria JE, Monzón M. Factors Involved in the Immunological Protection against Rabies Virus in Dogs in Spain. Vaccines (Basel). 2024 Mar 11;12(3):293. doi: 10.3390/vaccines12030293.
dc.identifier.doi10.3390/vaccines12030293
dc.identifier.e-issn2076-393X
dc.identifier.journalVaccines (Basel)
dc.identifier.pubmedID38543927
dc.identifier.urihttps://hdl.handle.net/20.500.12105/25995
dc.language.isoeng
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.publisherversionhttps://doi.org/10.3390/vaccines12030293
dc.repisalud.centroISCIII::Centro Nacional de Microbiología (CNM)
dc.repisalud.institucionISCIII
dc.rights.accessRightsopen access
dc.rights.licenseAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectOne Health
dc.subjectFactors affecting seroprevalence
dc.subjectImmune protection against rabies virus in dogs
dc.subjectRabies vaccine
dc.subjectSerum antibodies
dc.titleFactors Involved in the Immunological Protection against Rabies Virus in Dogs in Spain
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication5c7d63f5-f2f7-4056-a081-af18221680be
relation.isAuthorOfPublication.latestForDiscovery5c7d63f5-f2f7-4056-a081-af18221680be
relation.isFunderOfPublicationd9081f19-60cf-4e43-b80c-5f49c2e30a4d
relation.isFunderOfPublication.latestForDiscoveryd9081f19-60cf-4e43-b80c-5f49c2e30a4d
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
FactorsInvolvedImmunologicalProtection_2024.pdf
Size:
1.27 MB
Format:
Adobe Portable Document Format